Nanjing Medlander Financials
| 688273 Stock | 25.20 0.33 1.33% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 93.4 M | 74.4 M |
|
|
Nanjing | Select Account or Indicator |
Understanding current and past Nanjing Medlander Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Nanjing Medlander's financial statements are interrelated, with each one affecting the others. For example, an increase in Nanjing Medlander's assets may result in an increase in income on the income statement.
Please note, the presentation of Nanjing Medlander's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nanjing Medlander's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Nanjing Medlander's management manipulating its earnings.
Nanjing Medlander Stock Summary
Nanjing Medlander competes with Industrial, China Construction, Agricultural Bank, Bank of China, and PetroChina. Nanjing Medlander is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100005PV8 |
| Business Address | Building 5, Nanjing, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.medlander.com |
| Phone | 86 25 5771 9209 |
You should never invest in Nanjing Medlander without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Nanjing Stock, because this is throwing your money away. Analyzing the key information contained in Nanjing Medlander's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Nanjing Medlander Key Financial Ratios
Nanjing Medlander's financial ratios allow both analysts and investors to convert raw data from Nanjing Medlander's financial statements into concise, actionable information that can be used to evaluate the performance of Nanjing Medlander over time and compare it to other companies across industries.| Revenue | 340.82 M | ||||
| Gross Profit | 376.75 M | ||||
| Net Income | 89.82 M | ||||
| Total Asset | 1.53 B | ||||
| Retained Earnings | 244.7 M |
Nanjing Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanjing Medlander's current stock value. Our valuation model uses many indicators to compare Nanjing Medlander value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanjing Medlander competition to find correlations between indicators driving Nanjing Medlander's intrinsic value. More Info.Nanjing Medlander Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.50 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Nanjing Medlander Medical is roughly 2.01 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanjing Medlander by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanjing Medlander's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nanjing Medlander Medical Systematic Risk
Nanjing Medlander's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nanjing Medlander volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Nanjing Medlander Medical correlated with the market. If Beta is less than 0 Nanjing Medlander generally moves in the opposite direction as compared to the market. If Nanjing Medlander Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nanjing Medlander Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nanjing Medlander is generally in the same direction as the market. If Beta > 1 Nanjing Medlander moves generally in the same direction as, but more than the movement of the benchmark.
Nanjing Medlander Medical Total Assets Over Time
Nanjing Medlander Thematic Clasifications
Nanjing Medlander Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Nanjing Medlander November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Nanjing Medlander help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nanjing Medlander Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nanjing Medlander Medical based on widely used predictive technical indicators. In general, we focus on analyzing Nanjing Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nanjing Medlander's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.15 | |||
| Information Ratio | 0.0864 | |||
| Maximum Drawdown | 23.13 | |||
| Value At Risk | (4.74) | |||
| Potential Upside | 6.56 |
Complementary Tools for Nanjing Stock analysis
When running Nanjing Medlander's price analysis, check to measure Nanjing Medlander's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanjing Medlander is operating at the current time. Most of Nanjing Medlander's value examination focuses on studying past and present price action to predict the probability of Nanjing Medlander's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanjing Medlander's price. Additionally, you may evaluate how the addition of Nanjing Medlander to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets |